Symposia: Myeloproliferative Syndromes: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, adult, epidemiology, Translational Research, MPN, Non-Biological therapies, Clinical Research, genomics, Chronic Myeloid Malignancies, drug development, pediatric, Diseases, Therapies, registries, Myeloid Malignancies, Pharmacology, Biological Processes, molecular biology, Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Biological therapies, adult, epidemiology, Translational Research, MPN, Non-Biological therapies, Clinical Research, genomics, Chronic Myeloid Malignancies, drug development, pediatric, Diseases, Therapies, registries, Myeloid Malignancies, Pharmacology, Biological Processes, molecular biology, Study Population, Human
Saturday, December 9, 2023: 9:30 AM-11:00 AM
Ballroom 20AB
(San Diego Convention Center)
Moderators:
Natasha Szuber, MD, MSc, Mayo Clinic
and
Aaron T. Gerds, MD, MS, Cleveland Clinic Taussig Cancer Institute
Disclosures:
Gerds: AbbVie, Bristol Myers Squibb, Constellation Pharmaceuticals, GlaxoSmithKline, Kartos, Novartis, PharmaEssentia, Sierra Oncology: Consultancy; Accurate Pharmaceuticals, Constellation Pharmaceuticals, CTI BioPharma, Imago BioSciences, Incyte Corporation, Kratos Pharmaceuticals: Research Funding.
This session spotlights new clinical data and exciting therapeutic breakthroughs in uncommon myeloproliferative neoplasms. Together, these data will delineate the new therapeutic landscape of these rare diseases as it shifts from from desert island to promising new possibilities.
9:45 AM
10:00 AM
10:15 AM
10:30 AM
10:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH